Multiomic Analysis of Candida albicans Adaptation during Commensal Coexistence with Staphylococcus aureus

Changxia Zhou1,2, Jingling Wang2, Shenkun Wei1,2

  • 1School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.

ACS Chemical Biology
|November 26, 2025
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) alters Candida albicans virulence through changes in protein modifications. These post-translational modifications impact fungal metabolism and stress response, offering new anti-infective strategies.

Area of Science:

  • Microbiology
  • Mycology
  • Biochemistry

Background:

  • Candida albicans is a human fungal pathogen whose virulence is influenced by its microenvironment.
  • Interactions between C. albicans and bacteria like methicillin-resistant Staphylococcus aureus (MRSA) are common but poorly understood at the molecular level.

Purpose of the Study:

  • To investigate the impact of MRSA on protein expression and post-translational modifications (PTMs) in C. albicans.
  • To elucidate the molecular mechanisms underlying MRSA-mediated regulation of C. albicans physiology and pathogenicity.

Main Methods:

  • Integrative multiomics approach combining proteomics and PTM analysis.
  • In vitro enzyme activity assays to assess the functional impact of PTMs.

Main Results:

  • MRSA significantly altered the expression of virulence-associated proteins in C. albicans.
  • MRSA induced changes in protein phosphorylation and acetylation, particularly affecting energy metabolism, metabolic reprogramming, and stress response pathways.
  • Lysine acetylation modulated the activity of key enzymes like GAPDH and HIcDH, indicating a role in metabolic adaptation.

Conclusions:

  • MRSA regulates C. albicans physiology and pathogenicity through PTMs, notably acetylation and phosphorylation.
  • These findings provide a new framework for understanding fungal pathogenesis in polymicrobial infections.
  • The study suggests potential targets for developing novel anti-infective strategies against C. albicans in the context of bacterial co-infections.